Immunome
-
Neither the Pandemic Nor Labor Shortages Could Mute Phila.’s 2021 Venture Capital Boom
Despite the disruptions caused by the coronavirus pandemic and labor shortages, Philadelphia experienced a venture capital boom in 2021, write Taylor Allen and Mike D’Onofrio…
-
Exton-Based Biotech Company’s Stock Balloons After Discovering Antibodies That Neutralize COVID-19 Variants
Immunome saw its stock soar after the Exton-based company discovered antibodies that have shown, in early testing, the ability to neutralize multiple variants of COVID-19,…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
